Journal
FOOD RESEARCH INTERNATIONAL
Volume 92, Issue -, Pages 56-63Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.foodres.2016.12.017
Keywords
Olive leaf extract; Antiglycative activity; Advanced glycation end-products; Dicarbonyl compounds; Glycation
Categories
Funding
- Regional Government of Madrid
- European Regional Development Fund programme [S2013/ABI-3028-AVANSECAL]
- Spanish National Research Council [CSIC-201370E027]
- JAE programme (Spanish National Research Council)
Ask authors/readers for more resources
Advanced Glycation End-products (AGEs) have been associated to diabetes, neurodegenerative and cardiovascular diseases. Mitigating the formation of AGEs is a strategy to avoid detrimental physiopathological effects of age related chronic diseases. An olive leaf extract (OLE), obtained under acidic conditions, and two fractions, obtained by solid-phase extracticin, were characterized by LC-MS/MS. Antiglycative capacity of OLE and fractions were investigated in different in vitro models. The OLE significantly inhibited the formation of Amadori products at the early stage as well as the formation of fluorescent AGEs at the advanced stage of the glycation. Carboxymethyllysine was significantly inhibited by the OLE but it showed weaker activity against argpyrimidine and carboxyethyllysine. The antiglycative activity of each OLE fraction independently did not explain the activity reached in the whole extract, being necessary the compounds present in both fractions. OLE and its fractions were highly effective for trapping reactive dicarbonyl compounds (glyoxal, methylglyoxal, 3-deoxyglucosone and 3-deoxygalactosone). Different adducts resulting from the conjugation of methylglyoxal and hydroxytyrosol in OLE were identified. Results pointed out that OLE exert a broad-spectrum in vitro antiglycative activity. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available